Cargando…

Tissue-Specific Autoantibodies Improve Diagnosis of Primary Sjögren's Syndrome in the Early Stage and Indicate Localized Salivary Injury

Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease characterized by lymphocytic infiltration of exocrine glands. Due to the absence of specific clinical manifestations and biomarkers in the early stage, pSS is generally underrecognized. To elucidate the role of the tissue-specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Yuebo, Li, Jing, Chen, Jiali, Shao, Miao, Zhang, Ruijun, Liang, Yichen, Zhang, Xia, Zhang, Xiaoying, Zhang, Qin, Li, Fangting, Cheng, Yaobin, Sun, Xiaolin, He, Jing, Li, Zhanguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530237/ https://www.ncbi.nlm.nih.gov/pubmed/31205955 http://dx.doi.org/10.1155/2019/3642937

Ejemplares similares

Corneal nerve structure in patients with primary Sjögren’s syndrome in China
por: Li, Fangting, et al.
Publicado: (2021)

Therapeutic potential of targeting Tfr/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study
por: Miao, Miao, et al.
Publicado: (2021)

Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model
por: Wang, Yifan, et al.
Publicado: (2022)

Treatment of Active Idiopathic Inflammatory Myopathies by Low-Dose Interleukin-2: A Prospective Cohort Pilot Study
por: Miao, Miao, et al.
Publicado: (2021)

Salivary gland ultrasonography in primary Sjögren’s syndrome from diagnosis to clinical stratification: a multicentre study
por: Zhang, Xia, et al.
Publicado: (2021)

Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren’s syndrome
por: Wei, Pan, et al.
Publicado: (2015)

Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome
por: Gan, Yuzhou, et al.
Publicado: (2017)

Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial
por: He, Jing, et al.
Publicado: (2022)

A Rare Case of Neurosarcoidosis Overlapped with Sjogren’s Syndrome
por: Cai, Wenxin, et al.
Publicado: (2022)

The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome
por: Li, Linbo, et al.
Publicado: (2015)

Comparison of the deep immune profiling of B cell subsets between healthy adults and Sjögren’s syndrome
por: Feng, Ruiling, et al.
Publicado: (2022)

Double Negative B Cell Is Associated With Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remission
por: You, Xujie, et al.
Publicado: (2020)

Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial
por: Zhang, Xiaoying, et al.
Publicado: (2022)

Recent Advances of Salivary Gland Biopsy in Sjögren's Syndrome
por: Liao, Rui, et al.
Publicado: (2022)

Symptomatic hyponatremia induced by low-dose cyclophosphamide in patient with systemic lupus erythematosus: A case report
por: Chen, Jiali, et al.
Publicado: (2020)

Mucosal administration of α-fodrin inhibits experimental Sjögren's syndrome autoimmunity
por: He, Jing, et al.
Publicado: (2008)

Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE
por: Zhou, Haotian, et al.
Publicado: (2023)

Immunoassay Detects Salivary Anti-SSA/Ro-52 Autoantibodies in Seronegative Patients with Primary Sjögren’s Syndrome
por: Kamounah, Sarah, et al.
Publicado: (2023)

Identification of a novel autoantibody against self-vimentin specific in secondary Sjögren’s syndrome
por: Li, Yu-Hui, et al.
Publicado: (2018)

Anti-HMGB1 antibody is a potential characteristic autoantibody for Sjögren's syndrome
por: Chen, Mingkun, et al.
Publicado: (2022)

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
por: He, Jing, et al.
Publicado: (2020)

Salivary gland ultrasound is associated with the presence of autoantibodies in patients with Sjögren’s syndrome: A Danish single-centre study
por: Schmidt, Nanna Surlemont, et al.
Publicado: (2022)

Rapid serological detection of autoantibodies associated with Sjögren's syndrome
por: Burbelo, Peter D, et al.
Publicado: (2009)

Circulation autoantibody against Lamin A/C in patients with Sjögren's syndrome
por: Zhang, Wen, et al.
Publicado: (2016)

Autoantibodies in Sjögren's syndrome and its classification criteria
por: Veenbergen, Sharon, et al.
Publicado: (2021)

IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren’s Syndrome
por: Liang, Yichen, et al.
Publicado: (2021)

Composition and regulation of the immune microenvironment of salivary gland in Sjögren’s syndrome
por: Tan, Zhen, et al.
Publicado: (2022)

The Diagnostic Performance of Early Sjögren’s Syndrome Autoantibodies in Juvenile Sjögren’s Syndrome: The University of Florida Pediatric Cohort Study
por: Thatayatikom, Akaluck, et al.
Publicado: (2021)

Correlations Between Single-Photon Emission Computed Tomography Parameters of Salivary Glands and Dry Eye Tests in Patients With Sjögren's Syndrome
por: Huang, Xiaoyu, et al.
Publicado: (2022)

Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma
por: Cui, Li, et al.
Publicado: (2017)

Autoantibodies and Sjogren’s Syndrome in Multiple Sclerosis, a Reappraisal
por: Solomon, Andrew J., et al.
Publicado: (2013)

Evaluation of Autoantibodies in Patients with Primary and Secondary Sjogren’s Syndrome
por: De Langhe, Ellen, et al.
Publicado: (2017)

Alterations of CD8(+) T cells in the blood and salivary glands of patients with primary Sjögren’s syndrome
por: Li, Hongxia, et al.
Publicado: (2023)

The relationship between the presence of autoantibodies, indicators of local and systemic inflammation, the serum concentration of B-cell activating factor (BAFF) and the intensity of salivary gland infiltration in patients with primary Sjögren's syndrome – a preliminary study
por: Maślińska, Maria, et al.
Publicado: (2016)

Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjögren’s syndrome: A critical review
por: Vílchez-Oya, Francisco, et al.
Publicado: (2022)

Expression of CFTR, a hallmark gene of ionocytes, is downregulated in salivary glands of Sjögren’s syndrome patients
por: Zhang, Qi, et al.
Publicado: (2022)

Clinical features of Sjögren’s syndrome patients with autoantibodies against interferons
por: Burbelo, Peter D., et al.
Publicado: (2019)

Analysis of novel Sjogren’s syndrome autoantibodies in patients with dry eyes
por: Everett, Sandra, et al.
Publicado: (2017)

Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus
por: Shao, Miao, et al.
Publicado: (2018)

Epigenetic Signatures of Salivary Gland Inflammation in Sjögren's Syndrome
por: Cole, Michael B., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fhtakorv49euk2jqc76q7qss7h